EPITOL |
EPIMAZ |
TEGRETOL PROLONGED RELEASE |
TEGRETOL-XR |
TIMONIL 200 RET |
CARBAGEN SR |
EQUETRO |
TERIL |
NSC-169864 |
SIRTAL RET |
TERIL RET |
G-32883 |
GEIGY 32883 |
ARBIL MR |
CARBATROL |
CARNEXIV |
TIMONIL 400 RET |
TEGRETOL CHEWTAB |
EPIMAZ RET |
TEGRETOL XR |
CARBAMAZEPINE |
TEGRETOL |
5-CARBAMOYL-5H-DIBENZ[B,F]AZEPINE |
CBZ |
5-CARBAMOYL-5H-DIBENZO(B,F)AZEPINE |
5-CARBAMYL-5H-DIBENZO(B,F)AZEPINE |
5H-DIBENZ(B,F)AZEPINE-5-CARBOXAMIDE |
5-CARBAMOYL-5H-DIBENZ(B,F)AZEPINE |
CARBAMAZEPEN |
CARBAMAZEPINUM |
CALEPSIN |
TEGRETOL® |
CARBAMAZEPINA |
CARBAMAZEPIN |
CARBAMAZÉPINE |
TEG111 |
pubchem.compound:2554 |
chemidplus:298-46-4 |
chembl:CHEMBL108 |
rxcui:2002 |
drugbank:00564 |
Year of Approval | 1968 |
Drug Class | anticonvulsants |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | for treatment of bipolar disorder |
blocker (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Trial Name | SPD 417, carbamazepine,Equetro, Carbatrol |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
CARBAMAZEPINE | Primary Drug Name |
Drug Class | anticonvulsants |
Year of Approval | 1968 |
Drug Indications | for treatment of bipolar disorder |
Drug Class | Small Molecule |
FDA Approval | approved |
C341 | NCI drug code |
CHEMBL108 | ChEMBL Drug ID |
D04MSM | TTD Drug ID |